MBS Review Taskforce meeting outcomes, 7 February 2018

On 7 February 2018, the Medicare Benefits Schedule (MBS) Review Taskforce (the Taskforce) held its 26th meeting. The following is a summary of the outcomes arising from the meeting.

Page last updated: 13 July 2018

PDF version: MBS Review Taskforce meeting outcomes, 7 February 2018 (PDF 15 KB)

Pathology Clinical Committee Microbiology Report

The Taskforce endorsed the release of the Pathology Clinical Committee’s Microbiology Report for public consultation.

Pathology Clinical Committee Chemical Report

The Taskforce endorsed the release of the Pathology Clinical Committee’s Chemical Report for public consultation.

Diagnostic Imaging Clinical Committee Pulmonary Embolism and Deep Vein Thrombosis Recommendations

The Taskforce endorsed for Government the recommendations of the Diagnostic Imaging Clinical Committee’s Pulmonary Embolism and Deep Vein Thrombosis Working Group with one amendment.

Endocrinology Clinical Committee Recommendations

The Taskforce endorsed for Government the recommendations of the Endocrinology Clinical Committee with the exception of Recommendation 9 and with one minor amendment to Recommendation 6.

Upcoming Clinical Committees

The Taskforce discussed the work plans for clinical committees yet to be established, including the items to be reviewed by these committees.